"We are a clinical research site dedicated to medical innovation."

During the past decade, Biotech Pharmaceutical Group, LLC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Biotech Pharmaceutical Group, LLC" are "Migraine" (2 trials), "Asthma" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Biotech Pharmaceutical Group, LLC" in a lesser frequency.

Most popular intervention types in "Biotech Pharmaceutical Group, LLC" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gan & Lee Insulin Glargine Injection" (2 trials), "Lantus®" (2 trials), "Lasmiditan" (2 trials), "Placebo" (2 trials) and "Budesonide/Formoterol fumarate dihydrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Biotech Pharmaceutical Group, LLC" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Biotech Pharmaceutical Group, LLC". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Biotech Pharmaceutical Group, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Biotech Pharmaceutical Group, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".